Page 9 - EUREKA 2019_Neat

more focused on asking questions for
the sake of understanding instead of
critiquing what I had written.”
The six-month Boston placement
also exposed Vine to the concepts
of new app architectures that he had
not worked with before. “I feel a lot
more confident now that I can write
quality code in all of my future iOS
development endeavours,” says Vine.

Neuroscience graduate Elyn Rowe
pursued and found the right opportunities
at Carleton to create an impressive
research toolkit that launched her into a
PhD program right after her double major
undergrad years.
Awarded the Chancellor’s Medal
at spring Convocation for her
outstanding academic achievements,
Rowe began her research experience
at Carleton through a summer research
internship in Prof. Shawn Hayley’s lab.
“I worked with some amazing graduate
students investigating potential
therapeutics for Parkinson’s disease,
and they became some of my greatest
mentors and friends. I continued in this
lab through another internal research
opportunity at Carleton—I-CUREUS—
and learned a lot about overcoming
obstacles in research.”
From there, Rowe received funding
through the National Sciences and
Engineering Research Council of
Canada (NSERC) to work in Prof. Kyle
Biggar’s lab, where she stayed until
completing her undergraduate degree.
“It was in this lab where I discovered
my passion for cellular and molecular
biology, and ultimately flourished
as a scientist. With support from
Prof. Biggar and the rest of the lab, I
published two first-author scientific
papers and gained many skills that
I will take with me into my graduate
studies,” says Rowe.
“Kyle pushed me a lot and treated
me as if I were (already) a graduate
student. It was so worth it.”
Having learned the link between
self-motivation and success, Rowe
doggedly pursued professors willing
to work with her. She has relocated to
Vancouver and started her doctoral
studies in pathology and lab medicine
at the University of British Columbia.
“I will be working to further
understand and develop therapeutics
for Alzheimer’s disease,’’ says Rowe.

science.carleton.ca 9